Drug intelligence / Profile preview

1H-indole-2-hydroxy-3-carboxylic acid

Development stage
Preclinical
Modality
Small Molecules
01

Overview

1H-indole-2-hydroxy-3-carboxylic acid (IHCA) is a natural indole derivative and alkaloid isolated from the caper plant (*Capparis ovata*). It functions as a small molecule MDM2 inhibitor, which stabilizes the tumor suppressor protein p53 and induces p53-mediated apoptosis in cancer cells. Research indicates that IHCA increases the expression of tumor suppressor genes such as P53, PTEN, and RB, while downregulating oncogenic factors like KRAS and cell cycle regulators like CDK4. In vitro studies have demonstrated its efficacy against prostate cancer (LNCaP) and colorectal cancer (Caco-2) cell lines, showing superior binding stability to MDM2 compared to the reference inhibitor Nutlin-3a. It is currently being explored as a lead compound for anticancer drug development.

Other names
Indole-2-hydroxy-3-carboxylic acidIndole2-hydroxy-3-carboxylic acidIndole 2-hydroxy-3-carboxylic acid
02

Targets

CDK4 (Cyclin-dependent kinase 4)KRAS (Kirsten rat sarcoma viral oncogene homolog)MDM2 (Mouse double minute 2 homolog)PTEN (Phosphatase and tensin homolog deleted on chromosome ten)RB1 (Retinoblastoma-associated Protein)TP53 (Cellular Tumor Antigen p53 R175H)

Beyond the preview

Go deeper on 1H-indole-2-hydroxy-3-carboxylic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1H-indole-2-hydroxy-3-carboxylic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call